7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,884.90

-146.50

-3.63%

77,271.13

+52.70

+0.07%

Crude Oil Dec 26

102.95

+0.95

+0.93%

US Private Equity

10,850.63

-82.20

-0.75%

OTC Markets OTCPK - Delayed Quote USD

Merck KGaA (MKKGY)

33.66 -0.01 (-0.03%)

At close: October 30 at 3:56:50 PM EDT

Global Ribonucleic Acid (RNA) Interference Technology Market Report 2026-2030 | Capitalize on Precision Gene Silencing with Alnylam, Arrowhead, Silence Therapeutics, and Roche

GlobeNewswire 12h ago

ALNY

ROP.SW

TMO
Global Pooled CRISPR Screening Market Report 2026 | Capitalize on 16.1% CAGR as Thermo Fisher, Merck, Danaher and Agilent Accelerate AI-Driven Multi-Omics Workflows

GlobeNewswire 1d ago

TMO

DHR

A
Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?

Zacks 1d ago

RXRX

SNY

ROP.SW
MilliporeSigma Announces the Opening of €300 Million Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea

GlobeNewswire 1d ago

MRK.DE
Lisa Morales Joins Vinson & Elkins as NY-Based Corporate Partner

CorpGov.com 2d ago

JPM

ETOR

MRK.DE
Merck KGaA (MKKGY) Misses Q2 Earnings Estimates

Zacks 2mo ago

MKKGY
-0.03%
SXTP
Merck KGaA (MKKGY) Moves to Strong Buy: Rationale Behind the Upgrade

Zacks 3mo ago

MRK.DE

MKGAF

MKKGY
-0.03%
Should Value Investors Buy Merck KGaA (MKKGY) Stock?

Zacks 3mo ago

MRK.DE

MKGAF

MKKGY
-0.03%
Silence Therapeutics (SLN) Moves 7.2% Higher: Will This Strength Last?

Zacks 3mo ago

MKGAF

MKKGY
-0.03%
Are Investors Undervaluing Merck KGaA (MKKGY) Right Now?

Zacks 3mo ago

MKKGY
-0.03%
Company News for Jun 26, 2026

Zacks 4mo ago

BB.TO

META

MKC
Merck KGaA (MKKGY) Soars 5.3%: Is Further Upside Left in the Stock?

Zacks 4mo ago

MKKGY
-0.03%
DERM

Mobilize your Website

View Site in Mobile | Classic

Share by: